Provide an evaluation, a factual and independent opinion
on key issue or strategy proposed by a company, reporting strategic information in all sincerity, loyalty and transparency.
To certify that all the information provided during an audit is present in an expected final report.
Reveal the immaterial value of companies, validate the viability of an industrial project, estimate and validate the medical demand.
For any prescriber, adviser, buyer, or seller of a company
Before any financial transaction
As hunter and revealer of values and assets
A pioneer in asset valuation and non-accounting analysis of health business models, Mayakare agency contributes to improving methods for evaluating business performance.
More values : our firm was created with a unique value proposition to provide a robust holistic approach in transaction services, combining a triple skill implementing medical, financial and extra-financial accounting expertise.
More Confidence : Over the past five years, we have won the trust of our customers, with the highest expectations, and have successfully set a new standard and new good due diligence practice that fits any size from the start-up to the listed company.
More input : by building on this triple vision to go beyond raw analysis and put more human in the data set, while giving recommendations and helping our customers to implement them in the post-deal context.
More perspective : thanks to the skills of our talents and our internal methodology, we are convinced that we are helping to adopt and build new benchmarks thanks to a deep understanding of emerging economic models in health.
MayaKare intervenes in France, Geneva, Quebec, Belgium, Monaco, Luxembourg...
After a rigorous procedure of internal verification of information about Mayakare, supplemented by an external data analysis ; the GHP jury rewarded Mayakare because it fulfills a mission of the type "great contribution to the global Medtech industry".
His contribution to the GHP jury eyes is therefore remarkable on the following criteria:
Fabrice Romano, Président de Keranova
Julien Gillet Daubin, Fondateur et Directeur général de Neolys Diagnostics
Olivier Goulay Vice Président Elicit Plant
Josette Pratte, PDG Laboratoire Beepratte